	Negative findings from trials with NLY01 or deferiprone for Parkinson's disease - Author's reply. Lancet Neurol McGarry A. PMID: 38760092 [PubMed - indexed for MEDLINE]
	Negative findings from trials with NLY01 or deferiprone for Parkinson's disease. Lancet Neurol Müller T, Möhr JD. PMID: 38760091 [PubMed - indexed for MEDLINE]
	Understanding Role of Pesticides in Development of Parkinson's Disease: Insights from Drosophila and Rodent Models. Ageing Res Rev Afsheen S, Rehman AS, Jamal A, Khan N, Parvez S. PMID: 38759892 [PubMed - as supplied by publisher]
	Implication of regional selectivity of dopamine deficits in impaired suppressing of involuntary movements in Parkinson's disease. Neurosci Biobehav Rev Lee H, Kim HF, Hikosaka O. PMID: 38759470 [PubMed - as supplied by publisher]
	The Ethical Landscape of Prodromal Parkinson Disease: Considerations for Shared Decision-Making and Health Equity. Neurology Hoy CW, Chiong W. PMID: 38759135 [PubMed - indexed for MEDLINE]
	Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism. Neurology Hastings A, Cullinane P, Wrigley S, Revesz T, Morris HR, Dickson JC, Jaunmuktane Z, Warner TT, De Pablo-Fernández E. PMID: 38759132 [PubMed - indexed for MEDLINE]
	Identification of Prodromal Parkinson Disease: We May Be Able to But Should We? Neurology Rees RN, Noyce AJ, Schrag AE. PMID: 38759130 [PubMed - indexed for MEDLINE]
	Advice to People with Parkinson's in My Clinic: Cannabis. J Parkinsons Dis de Freitas MET, Fox SH. PMID: 38759024 [PubMed - as supplied by publisher]
	The Effect of taVNS at 25â€‰Hz and 100â€‰Hz on Parkinson's Disease Gait-A Randomized Motion Sensor Study. Mov Disord van Midden V, Simon, Pirto, Kojovi. PMID: 38757756 [PubMed - as supplied by publisher]
	Parkinson's disease with anxiety: clinical characteristics and their correlation with oxidative stress, inflammation, and pathological proteins. BMC Geriatr Lian T, Zhang W, Li D, Guo P, He M, Zhang Y, Li J, Guan H, Zhang W, Luo D, Zhang W, Wang X, Zhang W. PMID: 38755545 [PubMed - indexed for MEDLINE]
	[Multidisciplinary Complex Treatment of Parkinson's disease : Cornerstone of an individualized treatment]. Nervenarzt Scherbaum R, Tönges L. PMID: 38755423 [PubMed - as supplied by publisher]
	Does glial lipid dysregulation alter sleep in Alzheimer's and Parkinson's disease? Trends Mol Med Goodman LD, Moulton MJ, Lin G, Bellen HJ. PMID: 38755043 [PubMed - as supplied by publisher]
	Epigenetic Modifications in Parkinson's Disease: A Critical Review. Eur J Pharmacol Sharma R, Bisht P, Kesharwani A, Murti K, Kumar N. PMID: 38754537 [PubMed - as supplied by publisher]
	Global prevalence and incidence of Young Onset Parkinson's disease: A systematic review and meta-analysis. J Clin Neurosci Nabizadeh F, Seyedmirzaei H, Rafiei N, Maryam Vafaei S, Shekouh D, Mehrtabar E, Mirzaaghazadeh E, Mirzaasgari Z. PMID: 38754241 [PubMed - as supplied by publisher]
	Do Acoustic Characteristics of Dysarthria in People With Parkinson's Disease Differ Across Languages? J Speech Lang Hear Res Pinto S, Cardoso R, Atkinson-Clement C, Guimarães I, Sadat J, Santos H, Mercier C, Carvalho J, Cuartero MC, Oliveira P, Welby P, Frota S, Cavazzini E, Vigário M, Letanneux A, Cruz M, Brulefert C, Desmoulins M, Martins IP, Rothe-Neves R, Viallet F, Ferreira JJ. PMID: 38754039 [PubMed - as supplied by publisher]
	Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review. PLoS One Altham C, Zhang H, Pereira E. PMID: 38753740 [PubMed - indexed for MEDLINE]
	Harnessing Graphdiyne for Selective Cu(2+) Detection: A Promising Tool for Parkinson's Disease Diagnostics and Pathogenesis. ACS Sens Jiang J, Wang X, Bao Y, Shen F, Wang G, Li K, Lin Y. PMID: 38752502 [PubMed - as supplied by publisher]
	Assessing the factors that influence the utilization and delivery of rehabilitation services among persons with Parkinson's disease: A scoping review. J Eval Clin Pract Agoriwo MW, Joseph C, Franzén E, Unger M. PMID: 38752460 [PubMed - as supplied by publisher]
	A longitudinal evaluation of personalized intrinsic network topography and cognitive decline in Parkinson's disease. Eur J Neurosci Li R, Pozorski V, Dabbs K, Haebig M, Cox CR, Pletcher C, Wey A, Barzgari A, Theisen F, Okonkwo O, Gallagher CL. PMID: 38752411 [PubMed - as supplied by publisher]
	BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy. J Cell Mol Med Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, AlAseeri AA, Alruwaili M, Saad HM, Batiha GE. PMID: 38752280 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 50172

Page 1 of 2509



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy